4D Molecular Therapeutics
About
Company Overview
Purpose AND Strategy
LEADERSHIP TEAM
BOARD OF DIRECTORS
CONTACT US
Technology
GENE THERAPY
Conventional Vectors
4DMT Therapeutic Vector Evolution
SCIENTIFIC PRESENTATIONS
Product Pipeline
Pipeline Overview
Ophthalmology
Cardiology
Pulmonology
Patients
Overview
Clinical Trials
XLRP 4D-125
XLRP Natural History
CHM 4D-110
Wet AMD 4D-150
Fabry 4D-310
CF 4D-710
Advocacy Partners
Patient Stories
Resources
Investors
Overview
Events and Presentations
Press Releases
SEC Filings
Stock Information
Analyst Coverage
Corporate Governance
Careers and Culture
Overview and Openings
Competitive Compensation
BENEFITS, BALANCE and WELL-BEING
GROWTH AND DEVELOPMENT
CULTURE and COMMUNITY
Home
Terms of Use
Menu
About
LEADERSHIP TEAM
Katie Sullivan